Furthermore, the combination of YM155 and TRAIL synergistically induced caspase-dependent cell death via downregulation of both MCL-1 and Survivin [141], highlighting how YM155 may effectively target multiple resistance mechanisms within cancer cells. This evidence concerns the gene TNFSF10 and cancer.